AstraZeneca
AZN
AZN
396 hedge funds and large institutions have $8.72B invested in AstraZeneca in 2016 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 154 increasing their positions, 98 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
20% more capital invested
Capital invested by funds: $7.26B → $8.72B (+$1.46B)
2.46% more ownership
Funds ownership: 20.4% → 22.86% (+2.5%)
2% more funds holding
Funds holding: 388 → 396 (+8)
Holders
396
Holding in Top 10
4
Calls
$99.3M
Puts
$30.6M
Top Buyers
| 1 | +$223M | |
| 2 | +$196M | |
| 3 | +$124M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$112M |
| 5 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$92M |
Top Sellers
| 1 | -$69.1M | |
| 2 | -$65.8M | |
| 3 | -$39.3M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$23.1M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$18.5M |